CXCR3 and neoplasm: It is a chemokine that interacts with T cells by binding CXCR3, inducing the recruitment of CD8+ lymphocytes to the tumor microenvironment and inducing the differentiation of inflammatory T helper type 1 (Th1) and Th17 CD4 cells [31,77,78].